ScienceCrossing the borders of innovationBasing clinical trials on sound mechanistic and scientific rationale. Combating Pan-Cancer with PrecisionCombating Pan-Cancer with PrecisionSaving Lives of Patients Who Exhausted Treatment Options and Improving Clinical BenefitsPatient no boxCancer Patients are fighting for their lives...we will fight with themImagining a world without cancer. Apollomics is an innovative biopharmaceutical company committed to the discovery and development of oncology combination therapies. Pipeline Science Events Our Vision To become a global leader in the development of novel medicines for cancer patients. Learn More Recent News September 19, 2021 APOLLOMICS, INC. DOSES FIRST PATIENT IN A PHASE I CLINICAL TRIAL OF APL-102 May 20, 2021 APOLLOMICS INC. ANNOUNCES OFFICIAL OPENING OF SHANGHAI BRANCH More News
